Oncology Equipment For Medical Specialties
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat pleural mesothelioma and non-small-cell lung ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat hypercalcemia caused by malignant tumor or bone metastasis of multiple myeloma and solid cancer or prostate ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat breast cancer, non-small-cell lung cancer, prostate cancer, ovarian cancer, head and neck cancer, and esophageal ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat multiple myeloma, myelodysplastic syndrome, mantle cell lymphoma, and follicular ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat multiple myeloma or mantle cell ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat breast cancer, neuroendocrine tumor, ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat myelodysplastic syndrome or refractory anemia or ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat myelodysplastic syndrome or ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used as first-line therapy for ovarian cancer or breast cancer or lung ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used as treatment or post-surgery adjuvant therapy for metastatic colorectal cancer, colon cancer, advanced or metastatic gastric cancer, and stage II and III gastric ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used to treat follicular lymphoma, ...
-
PremiumManufactured by Samyang Corporationbased in SOUTH KOREA
Used alone or in combination to treat ovarian cancer or breast cancer or lung ...
-
Manufactured by Genekam Biotechnology AGbased in GERMANY
Isolation of circulating tumour cell kit with two markers and PCR Kit for Biomarkers of Melanoma from CTC. Human circulating tumour cells (CTC) in blood are an important indicator of the progression of a cancer and in some cases, these may be an indication of so called sleeping tumour cells i.e. it does mean that there is an active disease. Therefore PCR tests are being conducted in many ...
-
Manufactured by GeneCentric Therapeutics, Inc.based in USA
Head and Neck Cancer, a group of cancers that starts within the mouth, nose, throat, larynx, sinuses, or salivary glands, is the seventh most common of all cancers. Because most majority begin in squamous cells which line the moist surfaces inside the head and neck areas, such cancers are also referred to as Head and Neck Squamous Cell Carcinomas ...
-
Manufactured by Araris Biotech AGbased in SWITZERLAND
Araris Biotech AG, a spin-off company from the Paul Scherrer Institute (PSI) and ETH Zurich, is pioneering the development of a novel, proprietary antibody-drug conjugate (ADC)-linker technology. Our linker platform enables payload attachment to ‘off-the-shelf’ antibodies in one step without needing to re-engineer or reduce antibodies, resulting in highly homogenous, stable and potent ...
-
based in USA
Screening can save lives and money by detecting cancer at its earliest most treatable stages when the 5yr survival approaches 90% versus just 10% in later stages ...
-
Manufactured by miR Scientific, LLCbased in USA
miR Scientific is a precision healthcare company committed to improving public health by transforming cancer management globally. The company’s proprietary miR Disease Management Platform® was developed to revolutionize the standard of value-based care for cancers and initially focuses on urological cancers. The initial test delivered by the miR Disease Management Platform® is the ...
-
Manufactured by CDx Diagnostics Inc.based in USA
AI-powered diagnostic platform to help prevent esophageal cancer. Included in the Standard of Practice Guidelines for the screening and surveillance of Barrett’s esophagus, WATS3D is our proprietary diagnostic platform for identifying precancerous cells in the ...
-
Manufactured by Neuros Medical, Inc.based in USA
A growing amputee population: There are over two million people estimated to be living with limb loss in the United States today, and almost 185,000 people have an amputation each year.1 Causes of amputation include peripheral vascular disease, trauma, and cancer.1 Worse yet, the number of amputees is expected to double by ...
-
Manufactured by Kiadis Pharma NVbased in NETHERLANDS
K-NK002: A phase 2 clinical study evaluating haplo-identical NK cells to prevent post-transplant relapse in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). This study was designed based on promising clinical proof-of-concept data from MD Anderson Cancer Center. The phase 2 trial for K-NK002 will be conducted in collaboration with the Bone Marrow Transplant Clinical ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you